New York State Common Retirement Fund grew its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 4.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 523,592 shares of the company's stock after purchasing an additional 20,930 shares during the period. New York State Common Retirement Fund owned 0.25% of Bath & Body Works worth $15,875,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the company. Proficio Capital Partners LLC acquired a new position in Bath & Body Works during the fourth quarter valued at approximately $1,378,000. Sequoia Financial Advisors LLC raised its stake in shares of Bath & Body Works by 40.5% during the fourth quarter. Sequoia Financial Advisors LLC now owns 9,149 shares of the company's stock valued at $355,000 after purchasing an additional 2,635 shares during the period. EverSource Wealth Advisors LLC increased its stake in shares of Bath & Body Works by 109.7% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock worth $63,000 after buying an additional 852 shares during the last quarter. Avantax Advisory Services Inc. bought a new stake in shares of Bath & Body Works in the fourth quarter worth $285,000. Finally, Commonwealth Equity Services LLC acquired a new position in Bath & Body Works in the fourth quarter worth $242,000. 95.14% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on BBWI shares. Barclays reduced their price target on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a report on Friday, May 30th. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. JPMorgan Chase & Co. boosted their price target on shares of Bath & Body Works from $41.00 to $43.00 and gave the company an "overweight" rating in a report on Monday, May 19th. Morgan Stanley reduced their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Finally, Citigroup boosted their price target on shares of Bath & Body Works from $36.00 to $42.00 and gave the company a "buy" rating in a report on Tuesday, May 20th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.
View Our Latest Analysis on Bath & Body Works
Bath & Body Works Trading Up 0.3%
Bath & Body Works stock traded up $0.08 during trading hours on Friday, reaching $31.79. 4,055,565 shares of the company were exchanged, compared to its average volume of 5,262,039. The firm has a market cap of $6.73 billion, a price-to-earnings ratio of 8.48, a PEG ratio of 1.07 and a beta of 1.72. The stock has a 50-day moving average of $30.16 and a 200 day moving average of $32.25. Bath & Body Works, Inc. has a 12 month low of $24.94 and a 12 month high of $41.87.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The company had revenue of $1.40 billion during the quarter, compared to analysts' expectations of $1.42 billion. During the same period in the prior year, the business earned $0.38 earnings per share. Bath & Body Works's revenue for the quarter was up 2.9% compared to the same quarter last year. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.52%. Bath & Body Works's payout ratio is presently 21.33%.
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Further Reading

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.